Hyalex Orthopaedics earned FDA investigational device exemption for its Freestyle knee implant, opening up the door for clinical trials.
The Freestyle implant for knee surgery is designed for patients with cartilage damage and early osteoarthritis of the femoral condyle, according to a May 20 news release.
The upcoming study will take place at sites across the U.S. and Europe and will assess the safety and efficacy of the implant.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
